Peptide Research
RFK Jr., 14 Peptides, and FDA Category 2: Were Any Peptides Actually Approved?
In early March 2026, headlines began circulating across the biotechnology and peptide research community claiming that 14 peptides had been
CT-388 Peptide: Mechanism, Clinical Trial Results, and the Future of Metabolic Research
The field of metabolic research peptides has advanced dramatically in the last decade. Scientists studying appetite regulation, metabolic signaling, and
The Obesity Research Pipeline: Next-Generation Metabolic Compounds in Development (2025–2030)
The obesity drug market is undergoing one of the most dramatic transformations in pharmaceutical history. Only a few years ago,
UBT251 vs Retatrutide: The New Triple-Agonist Peptide Entering the GLP-1 Arms Race
The world of metabolic research peptides is evolving at an incredible pace. What began as a focus on GLP-1 receptor
Food Noise, Anhedonia, and GLP-1 Agonists: How Retatrutide and Tirzepatide Change Dopamine and Reward Pathways
Understanding How GLP-1 Compounds Modulate Appetite, Food Noise, and Reward Signaling GLP-1–based compounds have become a major focus in metabolic
Why Your Peptide Vial Looks the Same (Even When the MG Is Different)
Why You Can’t Judge a Peptide by the Size of the Puck One of the most common questions in peptide